Taxotere and Cisplatin as Induction Chemotherapy in Patients With Stage IIIa N2 Non Small Cell Lung Cancer (NSCLC).
Phase of Trial: Phase II
Latest Information Update: 17 Jul 2012
At a glance
- Drugs Cisplatin (Primary) ; Docetaxel (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 03 Sep 2005 New trial record.